Drug Trial Radar · NCT05059600
A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting
Last checked: Nov 20, 2026Latest source record: Sep 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
52
Actual
Start
Oct 8, 2021
Primary completion
Jul 14, 2022
Study completion Jul 14, 2022
Sponsor
- Lead sponsor
- Supernus Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 28, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study was to evaluate whether the safe-use conditions for administration of brexanolone (ZULRESSO®) can be implemented in a home setting.
Conditions
- Postpartum Depression
Interventions
ZULRESSO®Drug
Intravenous infusion of ZULRESSO®.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With At Least One Treatment-Emergent Adverse Event (TEAE) Leading to Dose Interruption/DiscontinuationTime frame: Up to Day 3
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Sage Investigational Site
Culver City, California
Virtual Site (recruiting nationwide)
Culver City, California
Sage Investigational Site
Miramar, Florida
Sage Investigational Site
Pompano Beach, Florida
Sage Investigational Site
New York, New York
Sage Investigational Site
League City, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.